UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice - Lee, A Y; Lee, C S; Egan, C A (Br J Ophthalmol, 2017)